Wolff Wiese Magana’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.61M | Buy |
3,351
+999
| +42% | +$779K | 1.62% | 17 |
|
|
2025
Q1 | $1.94M | Buy |
2,352
+555
| +31% | +$458K | 1.32% | 27 |
|
|
2024
Q4 | $1.39M | Buy |
1,797
+52
| +3% | +$40.1K | 0.92% | 40 |
|
|
2024
Q3 | $1.55M | Buy |
1,745
+35
| +2% | +$31K | 1.06% | 31 |
|
|
2024
Q2 | $1.55M | Buy |
1,710
+5
| +0.3% | +$4.53K | 1.23% | 29 |
|
|
2024
Q1 | $1.33M | Buy |
1,705
+170
| +11% | +$132K | 1.14% | 34 |
|
|
2023
Q4 | $895K | Sell |
1,535
-20
| -1% | -$11.7K | 0.85% | 42 |
|
|
2023
Q3 | $835K | Buy |
1,555
+1,398
| +890% | +$751K | 0.68% | 50 |
|
|
2023
Q2 | $73.6K | Sell |
157
-20
| -11% | -$9.38K | 0.06% | 159 |
|
|
2023
Q1 | $60.8K | Sell |
177
-4
| -2% | -$1.37K | 0.05% | 170 |
|
|
2022
Q4 | $66.2K | Sell |
181
-350
| -66% | -$128K | 0.06% | 159 |
|
|
2022
Q3 | $172K | Sell |
531
-38
| -7% | -$12.3K | 0.14% | 120 |
|
|
2022
Q2 | $185K | Buy |
569
+79
| +16% | +$25.7K | 0.14% | 116 |
|
|
2022
Q1 | $141K | Sell |
490
-13
| -3% | -$3.74K | 0.09% | 146 |
|
|
2021
Q4 | $139K | Sell |
503
-1
| -0.2% | -$276 | 0.09% | 167 |
|
|
2021
Q3 | $116K | Buy |
504
+13
| +3% | +$2.99K | 0.08% | 181 |
|
|
2021
Q2 | $113K | Buy |
491
+68
| +16% | +$15.7K | 0.08% | 173 |
|
|
2021
Q1 | $79K | Sell |
423
-146
| -26% | -$27.3K | 0.06% | 216 |
|
|
2020
Q4 | $96K | Buy |
+569
| New | +$96K | 0.08% | 184 |
|